by
Gus Iversen, Editor in Chief | October 30, 2024
For the first time, GE HealthCare is manufacturing the Omni Legend PET/CT scanner in the U.S., building the systems at its new production facility in Waukesha, Wisconsin.
The new production line is part of GE HealthCare’s commitment to the Wisconsin BioHealth Tech Hub, an initiative it joined as a founding partner less than a year ago, which aims to expand personalized medicine and manufacturing in the region.
The initiative, designated and funded by the U.S. Department of Commerce and led by BioForward Wisconsin, leverages the state's healthcare assets to expand manufacturing, for data sharing, and lab space while advancing breakthroughs in genomics, imaging, and big data analytics to meet future demands in theranostics and personalized care.
In line with the new production line, GE HealthCare announced that its 100th Omni Legend installation in the United States and Canada will take place “up the road” at the newly completed UW Health Eastpark Medical Center in Madison.
“We are committed to enabling the broad adoption of precision care across care areas and practice of more personalized medicine, including theranostics,” said Jay Hill, vice president, Advanced Technology, GE HealthCare. “Already, our Waukesha facility supports these efforts as a vital founding partner in the Wisconsin BioHealth Tech Hub for the development, production and delivery of next-generation imaging technology to increase diagnostic applications."
Launched in 2022, the Omni Legend PET/CT integrates AI and advanced digital processing to support early diagnosis and precision monitoring of treatment responses, which are critical in fields like oncology, neurology, and cardiology. The system is also scalable, making it adaptable to increasing demand, such as the anticipated rise in PET amyloid imaging for Alzheimer’s diagnosis.
GE HealthCare's Omni Legend PET/CT
The system’s AI-driven features, including Precision DL and auto-positioning technologies, are designed to improve image quality, operational efficiency, and patient throughput, helping clinicians make informed decisions faster. These innovations reflect the company’s broader efforts to drive the adoption of personalized, data-driven care across North America.
"Our team is working with the Tech Hub to support our shared goals of integrating of digital tools and individualized data sets from patients with these new technologies to take personalized medicine to a whole new level; and with the help of clinicians throughout the United States and Canada, increase the yield and value of diagnostics," Hill added. "Now, we are incredibly proud to include Omni Legend among the list of impressive technologies coming from the site.”